Risk of 4 obesity-related cancers after GLP-1 receptor agonist use

First published 30/04/2026

Last updated 30/04/2026

EU PAS number:

EUPAS1000000990

Study

Planned

Download as PDF

Documents

Study protocol

Initial protocol

Study protocol GLP1RA cancer.pdf

English (508.55 KB - PDF) View document

Study results

Study report

Other information

Study, other information

covariates.pdf

English (8.08 MB - PDF) View document